Search
Search Results
-
Comparison of Pakistani CKD-EPI, new Asian-modified CKD-EPI and revised Lund–Malmö study equations in a South Asian CKD population: a study from a Pakistani CKD cohort
BackgroundNewly proposed estimating glomerular filtration rate equations need to be studied, evaluated and compared for chronic kidney disease...
-
Medikamentöse Herzinsuffizienztherapie bei CKD
Patients with chronic kidney disease (CKD) exhibit an increased risk to develop heart failure and the presence of heart failure in CKD patients leads...
-
Patients with CKD Secondary to Glomerular Disorders have Lower Arterial Stiffness, as Compared to Hypertensive and Diabetic CKD
BackgroundChronic kidney disease (CKD) manifested as reduced GFR and/or albuminuria, has been known to accelerate arterial stiffness and early...
-
Rationale KHK-Diagnostik bei CKD
The cardiovascular comorbidity of patients with chronic kidney disease (CKD) is considerably increased; however, CKD patients often show atypical...
-
Clinical Outcomes in Patients with CKD and Rapid or Non-rapid eGFR Decline: A Report from the DISCOVER CKD Retrospective Cohort
IntroductionThis analysis examined the baseline characteristics and clinical outcomes of patients with chronic kidney disease (CKD) and rapid or...
-
Aktuelle Strategien zur kardiovaskulären Risikoreduktion bei CKD
BackgroundChronic kidney disease (CKD) is associated with substantially increased cardiovascular morbidity and mortality. This is due to the high...
-
Characteristics of hospitalized elderly patients with CKD: a comparison between elderly and non-elderly CKD based on a multicenter cross-sectional study
PurposeWe undertook a multicenter epidemiological survey among hospitalized patients with chronic kidney disease (CKD), aiming to reveal the...
-
Heilung oder Progress – die AKI‑CKD‑Transition
Acute kidney injury (AKI) is one of the most frequent causes of kidney function deterioration, especially in hospitalized patients. Most cases of AKI...
-
Diastolische Dysfunktion und HFpEF bei CKD
Cardiac and renal (dys)functions are closely linked. Common risk factors lead to simultaneous or sequential loss of function of both organs, and...
-
Inflammation and gut dysbiosis as drivers of CKD–MBD
Two decades ago, Kidney Disease: Improving Global Outcomes coined the term chronic kidney disease–mineral and bone disorder (CKD–MBD) to describe the...
-
Genetic biomarkers of cognitive impairment and dementia of potential interest in CKD patients
This review discusses genetic variants associated with cognitive dysfunction in chronic kidney disease (CKD) patients, emphasising the limited...
-
A case series of Fabry diseases with CKD in Japan
BackgroundIt is well known that kidney injury is vital organ damage in Fabry disease (FD). Renin–angiotensin system (RAS) inhibitors are known to...
-
Characterization of CKD illness representation profiles using patient-level factors
BackgroundIllness perceptions are the unique perspective individuals have on their illness, based on their context and experiences, and are...
-
Comparison of CG, CKD-EPI[AS] and CKD-EPI[ASR] equations to estimate glomerular filtration rate and predict mortality in treatment naïve people living with HIV in Zimbabwe
BackgroundRenal impairment in people living with HIV (PWH) in Sub-Saharan Africa is common and associated with increased morbidity and mortality. The...
-
CKD-G 3–5: Antikoagulation bei Vorhofflimmern und Thromboembolien
The decision about anticoagulation in patients with chronic kidney disease (CKD) and atrial fibrillation is difficult as such patients have a clearly...
-
Design and methods of an open-label, randomized controlled trial to evaluate the effect of pemafibrate on proteinuria in CKD patients (PROFIT-CKD)
BackgroundHypertriglyceridemia is increasingly considered a residual risk of cardiovascular disease in patients with chronic kidney disease (CKD)....
-
Myocardial work in chronic kidney disease: insights from the CPH-CKD ECHO Study
BackgroundMyocardial work is a novel echocardiographic measure that offers detailed insights into cardiac mechanics. We sought to characterize...
-
CKD-G 3–5: Antikoagulation bei Vorhofflimmern und Thromboembolien
The decision about anticoagulation in patients with chronic kidney disease (CKD) and atrial fibrillation is difficult as such patients have a clearly...
-
Increased Cardiovascular Risk in Young Patients with CKD and the Role of Lipid-Lowering Therapy
Purpose of ReviewChronic kidney disease (CKD) is associated with a significantly increased risk of cardiovascular disease (CVD). This review...
-
The differential effect of modern intravenous iron on fibroblast growth factor 23 and phosphate in non-dialysis dependent CKD – the exploratory randomized controlled double-blind ExplorIRON-CKD study
BackgroundIntravenous iron is commonly used in patients with non-dialysis-dependent chronic kidney disease (CKD). Modern intravenous iron compounds...
